Dog Skin Allergy Testing and Immunotherapy

Allergen-specific immunotherapy offers the only disease-modifying treatment for environmental allergies in dogs, potentially eliminating the need for lifelong symptomatic medication.

Key Facts

Atopic dermatitis affects approximately 10-15% of dogs and is the second most common skin disease
Intradermal skin testing or serology identifies specific allergens causing reactions
Immunotherapy works by gradually desensitizing the immune system to identified allergens
Success rates of 60-70% are typical for allergen-specific immunotherapy in dogs
Immunotherapy takes 6-12 months to show maximal benefit
Treatment is lifelong but may reduce allergen sensitivity over time

Welfare Considerations

Dogs with atopic dermatitis experience chronic itching, skin inflammation, recurrent infections, and the discomfort of constant self-trauma through scratching and chewing. Without allergen identification and targeted treatment, management relies on ongoing symptomatic medications with side effects and costs. Allergen-specific immunotherapy addresses the underlying immune dysregulation rather than just symptoms, potentially allowing many dogs to have significantly better skin health and reduced suffering over their lifetimes.

What You Can Do

Work with a veterinary dermatologist for comprehensive allergy evaluation including intradermal testing
Consider allergen-specific immunotherapy as a long-term treatment option for atopic dogs
Follow the immunotherapy protocol consistently as sporadic dosing reduces effectiveness
Monitor for systemic reactions to immunotherapy injections, particularly with the first doses
Combine immunotherapy with environmental allergen reduction for best outcomes